Maxacalcitol intravenous injection for dialysis 2.5μg “Nipro”, manufactured by Shionogi Pharma, contains Maxacalcitol. This injectable vitamin D3 analog is indicated for treating secondary hyperparathyroidism in patients receiving maintenance dialysis. It has a YJ code of 3112401A1050 and a standard of 2.5μg 1mL 1 tube.
Maxacalcitol intravenous injection for dialysis 2.5μg “Nipro”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →